Moreover, immunohistochemistry of 20 solid tumors including a maximum of 12 patients each, shows positive SUCNR1 staining in 42% of RCC patients compared to 25% in carcinoid and 9% in urothelial cancer patients (Figure 1B,C). This evidence concerns the gene SUCNR1 and carcinoid tumor.